Scientists
Discover Basic Defect In Cystic Fibrosis Airway Glands
Scientists at Stanford University have determined that the buildup
of sticky mucus found in cystic fibrosis is caused by a loss in the
epithelial cell's ability to secrete fluid. This research appears
as the "Paper of the Week" in the March 17 issue of the Journal of
Biological Chemistry, an American Society for Biochemistry and
Molecular Biology journal.
Cystic fibrosis is the most common, fatal genetic disease in the
United States. It causes the body to produce thick, sticky mucus
that builds up in the lungs and blocks the airways. This makes it
easy for bacteria to grow and leads to repeated serious lung
infections. The thick, sticky mucus can also block tubes in the
pancreas, preventing digestive enzymes from reaching the small
intestine.
The disorder results from mutations in the gene for the cystic
fibrosis transmembrane conductance regulator (CFTR), a membrane
channel regulator essential for proper salt and water movement
across some epithelia. Currently, there are two essentially
opposite explanations for the inability of the body to clear mucus
from the airways in cystic fibrosis. The first is that the
defective CFTR is unable to aid in fluid secretion in cystic
fibrosis airway glands. The second explanation is that the glands
still secrete fluid via non-CFTR pathways, but the fluid is
reabsorbed by other channels. In fact, it has been proposed that
one of CFTR's functions is to inhibit the activity of a channel
called the epithelial Na+ channel (ENaC).
Nam Soo Joo and colleagues at Stanford University attempted to
determine which hypothesis was correct by measuring the secretion
from glands from patients with cystic fibrosis and from normal
pigs. They added ENaC inhibitors to the glands to determine if the
channel plays a role in mucus clearance. The researchers found no
evidence that the inhibitors altered secretion rates in either
normal or cystic fibrosis glands. This suggested that loss of
CFTR-mediated fluid secretion is the culprit in cystic
fibrosis.
"We previously showed that cystic fibrosis airway glands have
defective gland secretion in response to certain drugs," explains
Joo. "The results of our present study provide evidence that the
defective cystic fibrosis gland secretion is not due to a
potentially excessive fluid reabsorption pathway within glands but
is due to most likely to a lack of fluid secretion from cystic
fibrosis glands."